Publication:
Pseudotyped murine leukemia virus for schistosome transgenesis: Approaches, methods and perspectives

dc.contributor.authorVictoria H. Mannen_US
dc.contributor.authorSutas Suttiprapaen_US
dc.contributor.authorDanielle E. Skinneren_US
dc.contributor.authorPaul J. Brindleyen_US
dc.contributor.authorGabriel Rinaldien_US
dc.contributor.otherGeorge Washington Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-09T01:46:54Z
dc.date.available2018-11-09T01:46:54Z
dc.date.issued2014-01-01en_US
dc.description.abstractDraft genome sequences for the human schistosomes, Schistosoma japonicum, S. mansoni and S. haematobium are now available. The schistosome genome contains ~11,000 protein encoding genes for which the functions of few are well understood. Nonetheless, the newly described gene products and novel non-coding RNAs represent potential intervention targets, and molecular tools are being developed to determine their importance. Over the past decade, noteworthy advances has been reported towards development of tools for gene manipulation of schistosomes, including gene expression perturbation by RNAi, and transient and stable transfection including transgenesis mediated by genome integration competent vectors. Retrovirus-mediated transgenesis is an established functional genomic approach for model species. It offers the means to establish gain- or loss-of-function phenotypes, supports vector-based RNA interference, and represents a powerful forward genetics tool for insertional mutagenesis. Murine leukemia virus (MLV) pseudotyped with vesicular stomatitis virus glycoprotein mediates somatic transgenesis in S. mansoni, and vertical transmission of integrated transgenes in S. mansoni has been demonstrated, leading the establishment of transgenic lines. In addition, MLV transgenes encoding antibiotic resistance allow the selection of MLV-transduced parasites with the appropriate antibiotics. Here we describe detailed methods to produce and quantify pseudotyped MLV particles for use in transducing developmental stages of schistosomes. Approaches to analyze MLV-transduced schistosomes, including qPCR and high throughput approaches to verify and map genome integration of transgenes are also presented. We anticipate these tools should find utility in genetic investigations in other laboratories and for other helminth pathogens of important neglected tropical diseases. © 2014 Springer International Publishing Switzerland.en_US
dc.identifier.citationTransgenic Research. Vol.23, No.3 (2014), 539-556en_US
dc.identifier.doi10.1007/s11248-013-9779-3en_US
dc.identifier.issn09628819en_US
dc.identifier.other2-s2.0-84899942150en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/33104
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84899942150&origin=inwarden_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titlePseudotyped murine leukemia virus for schistosome transgenesis: Approaches, methods and perspectivesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84899942150&origin=inwarden_US

Files

Collections